CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Sarepta Therapeutics, Inc. et al. vs. Genzyme Corporation et al.

Explore the PTAB proceeding IPR2026-00167 filed by Sarepta Therapeutics, Inc. et al. on 2025-12-02. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2026-00167

Filing Date

2025-12-02

Accorded Filing Date

2025-12-02

Institution Decision Date

2026-05-15

Last Modified Date

2026-07-28

Proceeding Type

IPR

Termination Date

2026-05-15

Trial Status

Institution Denied

Parties & Counsel

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 16325653
Respondent Patent Number 11698377
Legal Expiration Date
2038-08-08 Active (11.7 yrs remaining)
Patent Term Adjustment (PTA) +359 Days Awarded
Injunction Viability (35 U.S.C. ยง 283) Active Threat
Respondent Inventor Xiaoying JIN et al
Respondent Tech Center TC 1700 - Chemical & Materials Engineering

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1700 - Chemical & Materials Engineering

Decisions Rendered

1 Total

Proceeding Status

Institution Denied

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Board Decisions & Rulings (1)

Institution Denied 2026-05-15
Institution Decision: Deny
35 USC 314, 35 USC 324

Address and Attorney/Agent Information

40 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name Sanofi/Genzyme c/o Morrison & Foerster LLP
Customer Number 89300
Address 755 Page Mill Road, Palo Alto, CA, 94304, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
36844 Joseph Kirk Jr +1 908-981-6911
39150 John Conway +1 908-981-6688
40564 Anne Collins +1 978-341-0036
44045 Sandra Brockman-Lee +1 857-523-9199
45736 Pamela Torpey +1 508--27-1-0683
45979 Milan Vinnola +1 619-238-0062
47150 Nicole Parsons +1 617-685-5697
52610 Kelly Bender +1 248-593-0581

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

๐Ÿ‡บ๐Ÿ‡ธ
U.S. District Courts 1 proceeding
๐Ÿ›๏ธ
USPTO PTAB Trials 3 proceedings
๐Ÿ‡ช๐Ÿ‡บ
Unified Patent Court (UPC) Counterparts in force
๐Ÿ‡ฉ๐Ÿ‡ช
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): ๐Ÿ‡บ๐Ÿ‡ธ US ๐ŸŒ PCT
Parallel Proceedings Across Jurisdictions (4 found):
PTAB: 3 U.S. Courts: 1
USPTO PTAB Trial 2026-02-26
IPR2026-00270

Sarepta Therapeutics, Inc. et al. v. Genzyme Corporation et al.

U.S. Continuation Sibling (12298313)
Status: Institution Denied
USPTO PTAB Trial 2025-12-02
IPR2026-00166

Sarepta Therapeutics, Inc. et al. v. Genzyme Corporation et al.

U.S. Continuation Sibling (12298313)
Status: Terminated
USPTO PTAB Trial 2025-12-02
IPR2026-00168

Sarepta Therapeutics, Inc. et al. v. Genzyme Corporation et al.

U.S. Continuation Sibling (12123880)
Status: Institution Denied
U.S. District Court 2024-07-26
1:24-cv-00882

Genzyme Corporation v. Sarepta Therapeutics, Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

109
15

Notice of Refund NOTICE

2026-07-28 FILING PARTY: BOARD
14

Refund Request OTHER

2026-07-16 FILING PARTY: PETITIONER
13

Institution Decision: Deny DECISION

2026-05-15 FILING PARTY: BOARD
12

Director Discretionary Decision: Refer RESPONSE

2026-03-23 FILING PARTY: BOARD
1050

Ex. 1050 Exhibit

2026-03-04 FILING PARTY: PETITIONER

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc